论文部分内容阅读
为评价血脂康胶囊对颈动脉粥样硬化的影响 ,随机将合并颈动脉粥样硬化的高脂血症患者 30例分为血脂康组与洛伐他汀对照组 ,各 15例 ,用颈动脉彩色超声多普勒检测 ,记录颈动脉内膜 -中膜厚度(IMT) ,治疗 6个月后复查。结果显示 ,两组治疗后IMT均显著下降 ,与治疗前比较P <0 .0 5 ;组间比较无显著差异 (P >0 .0 5 )。表明血脂康与洛伐他汀均有减轻颈动脉粥样硬化的作用
To evaluate the effect of Xuezhikang capsule on carotid atherosclerosis, 30 patients with hyperlipidemia with carotid atherosclerosis were randomly divided into Xuezhikang group and Lovastatin control group, 15 cases in each group. Doppler ultrasound was performed to record the carotid intima-media thickness (IMT) and was reviewed after 6 months of treatment. The results showed that IMT decreased significantly after treatment in both groups, compared with P<0.05 before treatment; there was no significant difference between the two groups (P > 0.05). Shows that both Xuezhikang and Lovastatin can reduce carotid atherosclerosis